Goutaudier, Valentin
Sablik, Marta
Racapé, Maud
Rousseau, Olivia
Audry, Benoit
Kamar, Nassim
Raynaud, Marc
Aubert, Olivier
Charreau, Béatrice
Papuchon, Emmanuelle
Danger, Richard
Letertre, Laurence
Couzi, Lionel
Morelon, Emmanuel
Le Quintrec, Moglie
Taupin, Jean-Luc
Vicaut, Eric
Legendre, Christophe
Le Mai, Hoa
Potluri, Vishnu
Nguyen, Thi-Van-Ha
Azoury, Marie-Eliane
Pinheiro, Alice
Nouadje, Georges
Sonigo, Pierre
Anglicheau, Dany
Tieken, Ineke
Vogelaar, Serge
Jacquelinet, Christian
Reese, Peter
Gourraud, Pierre-Antoine
Brouard, Sophie
Lefaucheur, Carmen
Loupy, Alexandre http://orcid.org/0000-0003-3388-7747
,
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-17-RHUS-0010)
Article History
Received: 27 November 2023
Accepted: 4 March 2024
First Online: 16 April 2024
Declarations
:
: RD and SB have ownership interests in the BioMAdvanced Diagnostics company not involved in the present study. MEA, AP, GN and PS are employees of Sebia. AL holds shares in Predict4Health, a software company that is not involved in the present research. PAG is the founder of Methodomics (2008) and the co-founder of Big data Santé (2018). He consults for major pharmaceutical companies and start-ups, all of which are handled through academic pipelines (AstraZeneca, Biogen, Boston Scientific, Cook, Docaposte, Edimark, Ellipses, Elsevier, Janssen, Lek, Methodomics, Merck, Mérieux, Octopize, Sanofi-Genzyme). PAG is a volunteer board member at AXA not-for-profit mutual insurance company (2021). He has no prescription activity with either drugs or devices. The other authors declare no competing interests.